News

AddToAny

Google+ Facebook Twitter Twitter

3D human cell models

Medicines Discovery Catapult and the Medical Research Council Centre for Drug Safety Science at the University of Liverpool are collaborating.

They have agreed a memorandum of understanding to combine their academic and industry expertise in developing next generation 3D human cell models and creating robust cellular platforms.

Through the collaboration these will be available to UK drug discovery SMEs.

The first project to be undertaken under the new alliance will focus on the development of a next generation cardiac safety model. The human cell model will enable companies to measure a broader range of patient relevant toxicities in a single assay.

md.catapult.org.uk

Picture credit | Science Photo Library

Related Articles

May journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

p30-35-cancer-_dr-jhartwell-and-sr.-levy-kornberg_national-cancer-institute_edit-4colbw.jpg

War on cancer pt.2: landmarks in the development of chemotherapy

The second article of two, which briefly reviews the historical developments and use of chemotherapy since 1948 to treat different cancers. 
 

April: News in numbers

A breakdown of science news this month, in numbers.

Liquid biopsy for non-small cell lung cancer

A US multi-centre study revealed that a liquid biopsy is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced non-small cell lung cancer (NSCLC).

Top